Share Price and Basic Stock Data
Last Updated: November 4, 2025, 5:54 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Thirumalai Chemicals Ltd operates within the specialty chemicals sector, focusing on producing a range of chemical products. The company reported a sales figure of ₹2,132 Cr for the financial year ending March 2023, which marked a notable increase from ₹1,998 Cr in March 2022. However, sales for the trailing twelve months (TTM) stood at ₹1,945 Cr, indicating a slight decline compared to the previous fiscal year. Quarterly sales figures exhibited volatility, peaking at ₹621 Cr in June 2022 but subsequently declining to ₹431 Cr by March 2023. In the most recent quarters, sales showed a mixed trend, with ₹523 Cr in June 2023 and ₹542 Cr in September 2023, followed by a decrease to ₹492 Cr in December 2023. This inconsistency in revenue generation highlights potential challenges in sustaining growth amidst competitive pressures in the specialty chemicals market.
Profitability and Efficiency Metrics
Thirumalai Chemicals Ltd’s profitability metrics reveal significant challenges, with an operating profit margin (OPM) of -6% reported for the current fiscal year. The operating profit for the financial year ending March 2023 was ₹186 Cr, a substantial decline from ₹441 Cr in March 2022. The company recorded a net profit of -₹111 Cr, a stark contrast to the ₹90 Cr profit in the prior year. The quarterly performance further emphasizes this trend, with net profits falling consistently into negative territory in recent quarters, culminating in a net loss of ₹60 Cr in June 2025. Efficiency metrics such as return on equity (ROE) and return on capital employed (ROCE) also reflected distress, standing at 4.13% and 0.26%, respectively. Such figures are considerably low compared to industry norms, indicating operational inefficiencies and challenges in managing costs effectively.
Balance Sheet Strength and Financial Ratios
Thirumalai Chemicals Ltd’s balance sheet exhibits a concerning level of leverage, with total borrowings amounting to ₹1,786 Cr against reserves of ₹1,145 Cr. The long-term debt-to-equity ratio stood at 1.21, reflecting a high reliance on debt financing, which could raise liquidity risks if cash flows do not improve. The interest coverage ratio (ICR) is reported at 1.41, suggesting limited ability to meet interest obligations comfortably. Additionally, the current ratio of 1.04 indicates that the company barely meets its short-term liabilities, which is lower than the typical industry benchmark of above 1.5. The company’s price-to-book value (P/BV) ratio is at 2.15x, suggesting that the stock may be trading at a premium relative to its book value, which could deter potential investors if performance does not stabilize.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Thirumalai Chemicals Ltd reflects a diverse ownership structure, with promoters holding 36.13% as of August 2025. Foreign institutional investors (FIIs) possess 2.09%, while domestic institutional investors (DIIs) hold 9.12%. The public holds a significant 52.65% stake, indicating a broad base of retail investors. However, the promoter’s holding has decreased from 42.01% in December 2022 to 36.13% in August 2025, which may raise concerns regarding insider confidence in the company’s future. The number of shareholders has also declined from 81,997 in December 2022 to 59,510 in August 2025, suggesting potential disenchantment among investors. This decline in both promoter holding and shareholder numbers could impact the stock’s performance and investor sentiment, particularly in light of the company’s recent financial struggles.
Outlook, Risks, and Final Insight
Looking ahead, Thirumalai Chemicals Ltd faces a challenging landscape characterized by high debt levels and declining profitability. The company’s ability to navigate operational inefficiencies and improve cash flow will be critical. Strengths include its established presence in the specialty chemicals market and a diverse product portfolio, which can be leveraged for growth. Risks entail the high leverage, evident through significant borrowings and low-interest coverage, alongside the volatility in sales and profitability metrics. Should the company manage to stabilize its operational performance and enhance profitability, it could regain investor confidence. Conversely, continued financial underperformance may lead to further declines in shareholding and market capitalization. The company must strategically focus on cost management and operational efficiency to turn around its fortunes.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Thirumalai Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 465 Cr. | 50.6 | 86.7/42.6 | 28.3 | 20.0 | 0.79 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 37.7 Cr. | 76.8 | 103/56.0 | 16.8 | 87.4 | 1.30 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 48.7 Cr. | 717 | 1,140/600 | 53.0 | 670 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,797 Cr. | 83.7 | 114/78.0 | 25.3 | 20.7 | 0.60 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 755 Cr. | 302 | 453/241 | 27.1 | 91.1 | 0.83 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,752.68 Cr | 729.55 | 47.83 | 178.98 | 0.40% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 621 | 572 | 508 | 431 | 523 | 542 | 492 | 527 | 555 | 525 | 447 | 523 | 450 |
| Expenses | 525 | 511 | 479 | 432 | 485 | 527 | 498 | 523 | 524 | 502 | 467 | 508 | 477 |
| Operating Profit | 97 | 61 | 29 | -1 | 38 | 15 | -6 | 4 | 31 | 24 | -20 | 15 | -27 |
| OPM % | 16% | 11% | 6% | -0% | 7% | 3% | -1% | 1% | 6% | 4% | -5% | 3% | -6% |
| Other Income | 3 | 6 | 11 | 11 | 5 | 6 | 4 | 4 | 3 | 9 | 0 | 8 | 2 |
| Interest | 6 | 7 | 11 | 7 | 10 | 10 | 12 | 10 | 9 | 10 | 14 | 15 | 18 |
| Depreciation | 13 | 13 | 14 | 16 | 16 | 16 | 15 | 17 | 14 | 13 | 16 | 18 | 22 |
| Profit before tax | 81 | 47 | 14 | -13 | 17 | -4 | -29 | -19 | 11 | 9 | -50 | -11 | -64 |
| Tax % | 26% | 27% | 41% | 0% | 37% | 47% | -20% | 10% | 53% | 47% | -16% | 28% | -7% |
| Net Profit | 60 | 34 | 8 | -13 | 11 | -6 | -23 | -20 | 5 | 5 | -42 | -14 | -60 |
| EPS in Rs | 5.86 | 3.35 | 0.81 | -1.25 | 1.04 | -0.59 | -2.24 | -2.00 | 0.50 | 0.48 | -4.10 | -1.37 | -5.86 |
Last Updated: August 20, 2025, 2:15 am
Below is a detailed analysis of the quarterly data for Thirumalai Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 450.00 Cr.. The value appears to be declining and may need further review. It has decreased from 523.00 Cr. (Mar 2025) to 450.00 Cr., marking a decrease of 73.00 Cr..
- For Expenses, as of Jun 2025, the value is 477.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 508.00 Cr. (Mar 2025) to 477.00 Cr., marking a decrease of 31.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to -27.00 Cr., marking a decrease of 42.00 Cr..
- For OPM %, as of Jun 2025, the value is -6.00%. The value appears to be declining and may need further review. It has decreased from 3.00% (Mar 2025) to -6.00%, marking a decrease of 9.00%.
- For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Jun 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 4.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -64.00 Cr.. The value appears to be declining and may need further review. It has decreased from -11.00 Cr. (Mar 2025) to -64.00 Cr., marking a decrease of 53.00 Cr..
- For Tax %, as of Jun 2025, the value is -7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to -7.00%, marking a decrease of 35.00%.
- For Net Profit, as of Jun 2025, the value is -60.00 Cr.. The value appears to be declining and may need further review. It has decreased from -14.00 Cr. (Mar 2025) to -60.00 Cr., marking a decrease of 46.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -5.86. The value appears to be declining and may need further review. It has decreased from -1.37 (Mar 2025) to -5.86, marking a decrease of 4.49.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,275 | 1,070 | 940 | 1,028 | 1,312 | 1,261 | 1,085 | 1,086 | 1,998 | 2,132 | 2,083 | 2,050 | 1,945 |
| Expenses | 1,192 | 1,032 | 842 | 871 | 1,022 | 1,055 | 1,007 | 865 | 1,557 | 1,946 | 2,032 | 2,001 | 1,954 |
| Operating Profit | 83 | 38 | 98 | 158 | 290 | 206 | 78 | 221 | 441 | 186 | 51 | 49 | -9 |
| OPM % | 7% | 4% | 10% | 15% | 22% | 16% | 7% | 20% | 22% | 9% | 2% | 2% | -0% |
| Other Income | 3 | 8 | 5 | 4 | 7 | 12 | 21 | 7 | 12 | 30 | 19 | 21 | 20 |
| Interest | 49 | 35 | 23 | 17 | 13 | 12 | 17 | 21 | 20 | 31 | 42 | 49 | 58 |
| Depreciation | 23 | 18 | 25 | 36 | 31 | 36 | 44 | 50 | 57 | 56 | 63 | 61 | 69 |
| Profit before tax | 15 | -7 | 55 | 109 | 253 | 169 | 38 | 157 | 375 | 129 | -35 | -41 | -116 |
| Tax % | 20% | 102% | 41% | 35% | 33% | 33% | 39% | 25% | 25% | 31% | 12% | 13% | |
| Net Profit | 12 | -14 | 32 | 71 | 170 | 114 | 23 | 118 | 281 | 90 | -39 | -46 | -111 |
| EPS in Rs | 1.16 | -1.34 | 3.14 | 6.90 | 16.64 | 11.09 | 2.26 | 11.49 | 27.47 | 8.77 | -3.79 | -4.50 | -10.85 |
| Dividend Payout % | 0% | -30% | 51% | 27% | 12% | 18% | 0% | 19% | 9% | 17% | -26% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -216.67% | 328.57% | 121.88% | 139.44% | -32.94% | -79.82% | 413.04% | 138.14% | -67.97% | -143.33% | -17.95% |
| Change in YoY Net Profit Growth (%) | 0.00% | 545.24% | -206.70% | 17.56% | -172.38% | -46.88% | 492.87% | -274.91% | -206.11% | -75.36% | 125.38% |
Thirumalai Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 1% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -151% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 36% |
| 3 Years: | 9% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 0% |
| Last Year: | -4% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: July 25, 2025, 2:11 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 205 | 183 | 208 | 388 | 563 | 658 | 628 | 793 | 1,075 | 1,182 | 1,136 | 1,145 |
| Borrowings | 222 | 142 | 91 | 62 | 50 | 103 | 197 | 183 | 165 | 514 | 1,252 | 1,786 |
| Other Liabilities | 321 | 212 | 211 | 327 | 202 | 370 | 365 | 358 | 612 | 654 | 922 | 867 |
| Total Liabilities | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 |
| Fixed Assets | 230 | 243 | 256 | 317 | 310 | 383 | 550 | 513 | 596 | 671 | 712 | 1,251 |
| CWIP | 18 | 7 | 18 | 9 | 44 | 159 | 82 | 126 | 64 | 406 | 1,200 | 1,352 |
| Investments | 5 | 5 | 5 | 77 | 104 | 150 | 49 | 136 | 180 | 132 | 173 | 200 |
| Other Assets | 503 | 291 | 241 | 383 | 367 | 449 | 519 | 569 | 1,022 | 1,150 | 1,236 | 1,005 |
| Total Assets | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 |
Below is a detailed analysis of the balance sheet data for Thirumalai Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,145.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,136.00 Cr. (Mar 2024) to 1,145.00 Cr., marking an increase of 9.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1,786.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,252.00 Cr. (Mar 2024) to 1,786.00 Cr., marking an increase of 534.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 867.00 Cr.. The value appears to be improving (decreasing). It has decreased from 922.00 Cr. (Mar 2024) to 867.00 Cr., marking a decrease of 55.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,808.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,320.00 Cr. (Mar 2024) to 3,808.00 Cr., marking an increase of 488.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,251.00 Cr.. The value appears strong and on an upward trend. It has increased from 712.00 Cr. (Mar 2024) to 1,251.00 Cr., marking an increase of 539.00 Cr..
- For CWIP, as of Mar 2025, the value is 1,352.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,200.00 Cr. (Mar 2024) to 1,352.00 Cr., marking an increase of 152.00 Cr..
- For Investments, as of Mar 2025, the value is 200.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 200.00 Cr., marking an increase of 27.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,005.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,236.00 Cr. (Mar 2024) to 1,005.00 Cr., marking a decrease of 231.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,808.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,320.00 Cr. (Mar 2024) to 3,808.00 Cr., marking an increase of 488.00 Cr..
However, the Borrowings (1,786.00 Cr.) are higher than the Reserves (1,145.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -139.00 | -104.00 | 7.00 | 96.00 | 240.00 | 103.00 | -119.00 | 38.00 | 276.00 | -328.00 | 50.00 | 48.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 52 | 50 | 49 | 33 | 33 | 30 | 29 | 29 | 17 | 32 | 35 |
| Inventory Days | 74 | 42 | 38 | 82 | 59 | 84 | 69 | 74 | 74 | 76 | 55 | 57 |
| Days Payable | 59 | 38 | 92 | 139 | 53 | 119 | 123 | 129 | 141 | 118 | 113 | 103 |
| Cash Conversion Cycle | 82 | 56 | -3 | -8 | 39 | -2 | -24 | -26 | -39 | -25 | -26 | -11 |
| Working Capital Days | 3 | -8 | -15 | -5 | 37 | 4 | -5 | -19 | -23 | -61 | -93 | -57 |
| ROCE % | 14% | 7% | 24% | 33% | 49% | 26% | 7% | 20% | 35% | 11% | 0% | 0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 65,760 | 0.23 | 1.44 | 65,760 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Diluted EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Cash EPS (Rs.) | 1.46 | 2.38 | 14.21 | 32.99 | 16.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Revenue From Operations / Share (Rs.) | 200.15 | 203.43 | 208.23 | 195.14 | 106.03 |
| PBDIT / Share (Rs.) | 6.78 | 6.87 | 21.13 | 44.18 | 22.22 |
| PBIT / Share (Rs.) | 0.81 | 0.69 | 15.69 | 38.65 | 17.39 |
| PBT / Share (Rs.) | -3.99 | -3.37 | 12.64 | 36.66 | 15.34 |
| Net Profit / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| NP After MI And SOA / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| PBDIT Margin (%) | 3.38 | 3.37 | 10.14 | 22.63 | 20.95 |
| PBIT Margin (%) | 0.40 | 0.34 | 7.53 | 19.80 | 16.39 |
| PBT Margin (%) | -1.99 | -1.65 | 6.06 | 18.78 | 14.47 |
| Net Profit Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| NP After MI And SOA Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| Return on Networth / Equity (%) | -3.98 | -3.38 | 7.53 | 25.91 | 14.65 |
| Return on Capital Employeed (%) | 0.28 | 0.31 | 10.74 | 30.29 | 17.08 |
| Return On Assets (%) | -1.21 | -1.16 | 3.80 | 15.10 | 8.76 |
| Long Term Debt / Equity (X) | 1.21 | 0.70 | 0.12 | 0.12 | 0.19 |
| Total Debt / Equity (X) | 1.48 | 1.01 | 0.37 | 0.14 | 0.19 |
| Asset Turnover Ratio (%) | 0.57 | 0.73 | 1.01 | 1.02 | 0.73 |
| Current Ratio (X) | 1.04 | 1.10 | 1.22 | 1.86 | 1.90 |
| Quick Ratio (X) | 0.77 | 0.85 | 0.84 | 1.42 | 1.47 |
| Inventory Turnover Ratio (X) | 6.23 | 5.86 | 5.40 | 5.68 | 3.91 |
| Dividend Payout Ratio (NP) (%) | -22.21 | -39.59 | 28.49 | 8.01 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 68.26 | 62.92 | 17.59 | 6.66 | 0.00 |
| Earning Retention Ratio (%) | 122.21 | 139.59 | 71.51 | 91.99 | 0.00 |
| Cash Earning Retention Ratio (%) | 31.74 | 37.08 | 82.41 | 93.34 | 0.00 |
| Interest Coverage Ratio (X) | 1.41 | 1.69 | 6.92 | 22.21 | 10.88 |
| Interest Coverage Ratio (Post Tax) (X) | 0.06 | 0.07 | 3.87 | 14.81 | 6.63 |
| Enterprise Value (Cr.) | 3836.01 | 2961.10 | 1656.34 | 2334.91 | 725.01 |
| EV / Net Operating Revenue (X) | 1.87 | 1.42 | 0.77 | 1.17 | 0.66 |
| EV / EBITDA (X) | 55.27 | 42.09 | 7.66 | 5.16 | 3.19 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| Retention Ratios (%) | 122.21 | 139.59 | 71.50 | 91.98 | 0.00 |
| Price / BV (X) | 2.15 | 2.09 | 1.48 | 2.51 | 1.09 |
| Price / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| EarningsYield | -0.01 | -0.01 | 0.05 | 0.10 | 0.13 |
After reviewing the key financial ratios for Thirumalai Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Diluted EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 1.46, marking a decrease of 0.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 200.15. It has decreased from 203.43 (Mar 24) to 200.15, marking a decrease of 3.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.78. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.78, marking a decrease of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.81. This value is within the healthy range. It has increased from 0.69 (Mar 24) to 0.81, marking an increase of 0.12.
- For PBT / Share (Rs.), as of Mar 25, the value is -3.99. This value is below the healthy minimum of 0. It has decreased from -3.37 (Mar 24) to -3.99, marking a decrease of 0.62.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For PBDIT Margin (%), as of Mar 25, the value is 3.38. This value is below the healthy minimum of 10. It has increased from 3.37 (Mar 24) to 3.38, marking an increase of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 10. It has increased from 0.34 (Mar 24) to 0.40, marking an increase of 0.06.
- For PBT Margin (%), as of Mar 25, the value is -1.99. This value is below the healthy minimum of 10. It has decreased from -1.65 (Mar 24) to -1.99, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 5. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 8. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is -3.98. This value is below the healthy minimum of 15. It has decreased from -3.38 (Mar 24) to -3.98, marking a decrease of 0.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 10. It has decreased from 0.31 (Mar 24) to 0.28, marking a decrease of 0.03.
- For Return On Assets (%), as of Mar 25, the value is -1.21. This value is below the healthy minimum of 5. It has decreased from -1.16 (Mar 24) to -1.21, marking a decrease of 0.05.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.21. This value exceeds the healthy maximum of 1. It has increased from 0.70 (Mar 24) to 1.21, marking an increase of 0.51.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.48. This value exceeds the healthy maximum of 1. It has increased from 1.01 (Mar 24) to 1.48, marking an increase of 0.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.73 (Mar 24) to 0.57, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 1.5. It has decreased from 1.10 (Mar 24) to 1.04, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.77, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.23. This value is within the healthy range. It has increased from 5.86 (Mar 24) to 6.23, marking an increase of 0.37.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -22.21. This value is below the healthy minimum of 20. It has increased from -39.59 (Mar 24) to -22.21, marking an increase of 17.38.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 68.26. This value exceeds the healthy maximum of 50. It has increased from 62.92 (Mar 24) to 68.26, marking an increase of 5.34.
- For Earning Retention Ratio (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 31.74. This value is below the healthy minimum of 40. It has decreased from 37.08 (Mar 24) to 31.74, marking a decrease of 5.34.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 3. It has decreased from 1.69 (Mar 24) to 1.41, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 3. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,836.01. It has increased from 2,961.10 (Mar 24) to 3,836.01, marking an increase of 874.91.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.87, marking an increase of 0.45.
- For EV / EBITDA (X), as of Mar 25, the value is 55.27. This value exceeds the healthy maximum of 15. It has increased from 42.09 (Mar 24) to 55.27, marking an increase of 13.18.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For Retention Ratios (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Price / BV (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 2.15, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Thirumalai Chemicals Ltd:
- Net Profit Margin: -2.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.28% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -3.98% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.06
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.77
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 47.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -2.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Thirumalai House, Mumbai Maharashtra 400022 | Info@thirumalaichemicals.com http://www.thirumalaichemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R Parthasarathy | Chairman & Managing Director |
| Mrs. Ramya Bharathram | Managing Director & CFO |
| Mr. P Mohana Chandran Nair | Director |
| Mr. Arun Alagappan | Director |
| Mrs. Bhama Krishnamurthy | Director |
| Mr. Arun Ramanathan | Director |
| Mr. R Sampath | Director |
| Mr. Rajeev M Pandia | Director |
| Mr. M Somasundaram | Director |
FAQ
What is the intrinsic value of Thirumalai Chemicals Ltd?
Thirumalai Chemicals Ltd's intrinsic value (as of 04 November 2025) is 57.12 which is 79.67% lower the current market price of 281.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,877 Cr. market cap, FY2025-2026 high/low of 395/201, reserves of ₹1,145 Cr, and liabilities of 3,808 Cr.
What is the Market Cap of Thirumalai Chemicals Ltd?
The Market Cap of Thirumalai Chemicals Ltd is 2,877 Cr..
What is the current Stock Price of Thirumalai Chemicals Ltd as on 04 November 2025?
The current stock price of Thirumalai Chemicals Ltd as on 04 November 2025 is 281.
What is the High / Low of Thirumalai Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Thirumalai Chemicals Ltd stocks is 395/201.
What is the Stock P/E of Thirumalai Chemicals Ltd?
The Stock P/E of Thirumalai Chemicals Ltd is .
What is the Book Value of Thirumalai Chemicals Ltd?
The Book Value of Thirumalai Chemicals Ltd is 113.
What is the Dividend Yield of Thirumalai Chemicals Ltd?
The Dividend Yield of Thirumalai Chemicals Ltd is 0.00 %.
What is the ROCE of Thirumalai Chemicals Ltd?
The ROCE of Thirumalai Chemicals Ltd is 0.26 %.
What is the ROE of Thirumalai Chemicals Ltd?
The ROE of Thirumalai Chemicals Ltd is 4.13 %.
What is the Face Value of Thirumalai Chemicals Ltd?
The Face Value of Thirumalai Chemicals Ltd is 1.00.